Clinical Trial Update: CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

The document notes a Phase 2 clinical trial evaluating CMOEP for untreated Peripheral T-cell lymphoma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CMOEP

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: RECRUITING